CoChat

The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state

Broglio, F., Gianotti, L., Destefanis, S., Fassino, S., Abbate Daga, G., Mondelli, V., Lanfranco, F., Gottero, C., Gauna, C., Hofland, L., Van der Lely, A. J., Ghigo, E. · 2004 · Clinical Endocrinology
Cited by 129

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Summary: objective Ghrelin, a gastric‐derived natural ligand of the GH secretagogue (GHS)‐receptor (GHS‐R), strongly stimulates GH secretion but also possesses other neuroendocrine actions, stimulates food intake and modulates the endocrine pancreas and energy homeostasis. Ghrelin secretion is negatively modulated by food intake. Similarly, glucose and also insulin probably exert an inhibitory effect on ghrelin secretion. Fasting ghrelin levels are reduced in obesity, elevated in anorexia nervosa and restored by weight recovery. The chronic elevation of circulating ghrelin levels in anorexia suggested the hypothesis of an alteration of the sensitivity to the orexigenic action of ghrelin in this condition. The aim of this study was to define the endocrine actions of ghrelin in patients with anorexia nervosa. design We enrolled nine women with anorexia nervosa of restricter type [AN; age (mean ± SEM) 24·2 ± 1·8 years; body mass index (BMI) 14·7 ± 0·4 kg/m 2] and seven normal young women in their early follicular phase as control group (NW; age 30·6 ± 3·1 years; BMI 20·3 ± 0·5 kg/m 2). measurements In all the subjects we studied the GH, PRL, ACTH, cortisol, insulin and glucose responses to acute ghrelin administration (1·0 µg/kg as i.v. bolus). The GH response to GHRH (1·0 µg/kg as i.v. bolus) and basal ghrelin and IGF‐I levels were also evaluated in all the subjects. results Basal morning ghrelin and GH levels in AN (643·6 ± 21·3 ng/l and 10·4 ± 0·5 µg/l, respectively) were higher (P < 0·05) than in NW (233·5 ± 14·2 ng/l and 0·7 ± 0·7 µg/l, respectively). However, IGF‐I levels in AN (145·3 ± 10·9 µg/l) were lower (P < 0·05) than in NW (325·4 ± 12·6 µg/l). The GH response to GHRH in AN was higher (P < 0·05) than that in NW, but in AN the GH response to ghrelin was lower (P < 0·05) than that in NW. In AN and NW ghrelin also induced similar increases (P < 0·05) in PRL, ACTH and cortisol levels. Ghrelin administration was followed by significant increase in glucose levels in NW (P < 0·05) but not in AN. conclusions This study demonstrates that anorexia nervosa, a clinical condition of ghrelin hypersecretion, shows a specific reduction in the GH response to ghrelin, despite the hyper‐responsiveness to GHRH administration. The impaired GH response to ghrelin in anorexia nervosa agrees with previous evidence of blunted GH response to synthetic GH secretagogues and could reflect desensitization of the GHS receptor induced by the chronic elevation of ghrelin levels in this pathological state.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2004.02011.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

Metadata

Authors
Broglio, F., Gianotti, L., Destefanis, S., Fassino, S., Abbate Daga, G., Mondelli, V., Lanfranco, F., Gottero, C., Gauna, C., Hofland, L., Van der Lely, A. J., & Ghigo, E.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2004-03-16
Volume
60
Issue
5
Pages
592-599
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2092709199
Cited by
129
References
5
FWCI
2.75
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.